|
1
|
Bernard GR, Artigas A, Brigham KL, et al:
The American-European Consensus Conference on ARDS. Definitions,
mechanisms, relevant outcomes, and clinical trial coordination. Am
J Respir Crit Care Med. 149:818–824. 1994. View Article : Google Scholar
|
|
2
|
Fowler AA, Hamman RF, Good JT, et al:
Adult respiratory distress syndrome: risk with common
predispositions. Ann Intern Med. 98:593–597. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pepe PE, Potkin RT, Reus DH, Hudson LD and
Carrico CJ: Clinical predictors of the adult respiratory distress
syndrome. Am J Surg. 144:124–130. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rinaldo JE and Christman JW: Mechanisms
and mediators of the adult respiratory distress syndrome. Clin
Chest Med. 11:621–632. 1990.PubMed/NCBI
|
|
5
|
Ware LB and Matthay MA: Alveolar fluid
clearance is impaired in the majority of patients with acute lung
injury and the acute respiratory distress syndrome. Am J Respir
Crit Care Med. 163:1376–1383. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matthay MA, Robriquet L and Fang X:
Alveolar epithelium: role in lung fluid balance and acute lung
injury. Proc Am Thorac Soc. 2:206–213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Canessa CM, Schild L, Buell G, et al:
Amiloride-sensitive epithelial Na+ channel is made of
three homologous subunits. Nature. 367:463–467. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deng W, Li CY, Tong J, Zhang W and Wang
DX: Regulation of ENaC-mediated alveolar fluid clearance by insulin
via PI3K/Akt pathway in LPS-induced acute lung injury. Respir Res.
13:292012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bellingan GJ: The pulmonary physician in
critical care * 6: The pathogenesis of ALI/ARDS. Thorax.
57:540–546. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goodman RB, Strieter RM, Martin DP, et al:
Inflammatory cytokines in patients with persistence of the acute
respiratory distress syndrome. Am J Respir Crit Care Med.
154:602–611. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tomashefski JF Jr: Pulmonary pathology of
acute respiratory distress syndrome. Clin Chest Med. 21:435–466.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johnson JL, Moore EE, Tamura DY, Zallen G,
Biffl WL and Silliman CC: Interleukin-6 augments neutrophil
cytotoxic potential via selective enhancement of elastase release.
J Surg Res. 76:91–94. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kiehl MG, Ostermann H, Thomas M, Müller C,
Cassens U and Kienast J: Inflammatory mediators in bronchoalveolar
lavage fluid and plasma in leukocytopenic patients with septic
shock-induced acute respiratory distress syndrome. Crit Care Med.
26:1194–1199. 1998. View Article : Google Scholar
|
|
14
|
Martin TR: Lung cytokines and ARDS: Roger
S. Mitchell Lecture. Chest. 116(Suppl 1): 2S–8S. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meduri GU, Kanangat S, Stefan J, Tolley E
and Schaberg D: Cytokines IL-1beta, IL-6, and TNF-alpha enhance in
vitro growth of bacteria. Am J Respir Crit Care Med. 160:961–967.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park WY, Goodman RB, Steinberg KP, et al:
Cytokine balance in the lungs of patients with acute respiratory
distress syndrome. Am J Respir Crit Care Med. 164:1896–1903. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Headley AS, Tolley E and Meduri GU:
Infections and the inflammatory response in acute respiratory
distress syndrome. Chest. 111:1306–1321. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meduri GU, Kohler G, Headley S, Tolley E,
Stentz F and Postlethwaite A: Inflammatory cytokines in the BAL of
patients with ARDS. Persistent elevation over time predicts poor
outcome. Chest. 108:1303–1314. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li SH and Chu Y: Anti-inflammatory effects
of total saponins of Panax notoginseng. Zhongguo Yao Li Xue
Bao. 20:551–554. 1999.PubMed/NCBI
|
|
20
|
Ng TB: Pharmacological activity of sanchi
ginseng (Panax notoginseng). J Pharm Pharmacol.
58:1007–1019. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun K, Wang CS, Guo J, et al: Protective
effects of ginsenoside Rb1, ginsenoside Rg1, and notoginsenoside R1
on lipopolysaccharide-induced microcirculatory disturbance in rat
mesentery. Life Sci. 81:509–518. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rong L, Chen Y, He M and Zhou X: Panax
notoginseng saponins attenuate acute lung injury induced by
intestinal ischaemia/reperfusion in rats. Respirology. 14:890–898.
2009. View Article : Google Scholar
|
|
23
|
Wang HM, Bodenstein M and Markstaller K:
Overview of the pathology of three widely used animal models of
acute lung injury. Eur Surg Res. 40:305–316. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vadász I, Morty RE, Kohstall MG, et al:
Oleic acid inhibits alveolar fluid reabsorption: a role in acute
respiratory distress syndrome? Am J Respir Crit Care Med.
171:469–479. 2005.PubMed/NCBI
|
|
25
|
Adebamiro A, Cheng Y, Johnson JP and
Bridges RJ: Endogenous protease activation of ENaC: effect of
serine protease inhibition on ENaC single channel properties. J Gen
Physiol. 126:339–352. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baines DL, Albert AP, Hazell MJ, Gambling
L, Woollhead AM and Dockrell ME: Lipopolysaccharide modifies
amiloride-sensitive Na+ transport processes across human
airway cells: role of mitogen-activated protein kinases ERK 1/2 and
5. Pflugers Arch. 459:451–463. 2010.PubMed/NCBI
|
|
27
|
Shen JF, Qiu HB, Yang Y, et al: Comparison
of single-indicator thermodilution versus gravimetric measurement
in determination of extra-vascular lung water in dogs with acute
respiratory distress syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi
Xue. 18:327–330. 2006.(In Chinese).
|
|
28
|
Walley KR, Lukacs NW, Standiford TJ,
Strieter RM and Kunkel SL: Balance of inflammatory cytokines
related to severity and mortality of murine sepsis. Infect Immun.
64:4733–4738. 1996.PubMed/NCBI
|
|
29
|
Chen C, Zhang F, Xia ZY, Lin H and Mo AS:
Protective effects of pretreatment with Radix Paeoniae Rubra
on acute lung injury induced by intestinal ischemia/reperfusion in
rats. Chin J Traumatol. 11:37–41. 2008.
|
|
30
|
Türüt H, Kurutas EB, Bulbuloglu E, et al:
Zinc aspartate alleviates lung injury induced by intestinal
ischemia-reperfusion in rats. J Surg Res. 151:62–67.
2009.PubMed/NCBI
|
|
31
|
Ware LB and Matthay MA: The acute
respiratory distress syndrome. N Engl J Med. 342:1334–1349. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Casey LC, Balk RA and Bone RC: Plasma
cytokine and endotoxin levels correlate with survival in patients
with the sepsis syndrome. Ann Intern Med. 119:771–778. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hack CE, Hart M, van Schijndel RJ, et al:
Interleukin-8 in sepsis: relation to shock and inflammatory
mediators. Infect Immun. 60:2835–2842. 1992.PubMed/NCBI
|
|
34
|
Meduri GU, Headley S, Kohler G, et al:
Persistent elevation of inflammatory cytokines predicts a poor
outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent
and efficient predictors of outcome over time. Chest.
107:1062–1073. 1995. View Article : Google Scholar
|
|
35
|
Pinsky MR, Vincent JL, Deviere J, Alegre
M, Kahn RJ and Dupont E: Serum cytokine levels in human septic
shock. Relation to multiple-system organ failure and mortality.
Chest. 103:565–575. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun K, Wang CS, Guo J, et al: Effect of
Panax notoginseng saponins on lipopolysaccharide-induced
adhesion of leukocytes in rat mesenteric venules. Clin Hemorheol
Microcirc. 34:103–108. 2006.
|
|
37
|
Nelson S, Bagby GJ, Bainton BG, Wilson LA,
Thompson JJ and Summer WR: Compartmentalization of intraalveolar
and systemic lipopolysaccharide-induced tumor necrosis factor and
the pulmonary inflammatory response. J Infect Dis. 159:189–194.
1989. View Article : Google Scholar
|
|
38
|
Tutor JD, Mason CM, Dobard E, Beckerman
RC, Summer WR and Nelson S: Loss of compartmentalization of
alveolar tumor necrosis factor after lung injury. Am J Respir Crit
Care Med. 149:1107–1111. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Steinberg KP, Mitchell DR, Maunder RJ,
Milberg JA, Whitcomb ME and Hudson LD: Safety of bronchoalveolar
lavage in patients with adult respiratory distress syndrome. Am Rev
Respir Dis. 148:556–561. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Standiford TJ, Kunkel SL, Phan SH, Rollins
BJ and Strieter RM: Alveolar macrophage-derived cytokines induce
monocyte chemoattractant protein-1 expression from human pulmonary
type II-like epithelial cells. J Biol Chem. 266:9912–9918.
1991.
|
|
41
|
Suter PM, Suter S, Girardin E,
Roux-Lombard P, Grau GE and Dayer JM: High bronchoalveolar levels
of tumor necrosis factor and its inhibitors, interleukin-1,
interferon, and elastase, in patients with adult respiratory
distress syndrome after trauma, shock, or sepsis. Am Rev Respir
Dis. 145:1016–1022. 1992. View Article : Google Scholar
|
|
42
|
Moriceau G, Ory B, Gobin B, et al:
Therapeutic approach of primary bone tumours by bisphosphonates.
Curr Pharm Des. 16:2981–2987. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Papanicolaou DA, Wilder RL, Manolagas SC
and Chrousos GP: The pathophysiologic roles of interleukin-6 in
human disease. Ann Intern Med. 128:127–137. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fiorentino DF, Zlotnik A, Mosmann TR,
Howard M and O’Garra A: IL-10 inhibits cytokine production by
activated macrophages. J Immunol. 147:3815–3822. 1991.PubMed/NCBI
|
|
45
|
Ramani M, Ollivier V, Khechai F, et al:
Interleukin-10 inhibits endotoxin-induced tissue factor mRNA
production by human monocytes. FEBS Lett. 334:114–116. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Standiford TJ, Strieter RM, Lukacs NW and
Kunkel SL: Neutralization of IL-10 increases lethality in
endotoxemia. Cooperative effects of macrophage inflammatory
protein-2 and tumor necrosis factor. J Immunol. 155:2222–2229.
1995.
|
|
47
|
van der Poll T, Marchant A, Buurman WA, et
al: Endogenous IL-10 protects mice from death during septic
peritonitis. J Immunol. 155:5397–5401. 1995.PubMed/NCBI
|
|
48
|
Donnelly SC, Strieter RM, Reid PT, et al:
The association between mortality rates and decreased
concentrations of interleukin-10 and interleukin-1 receptor
antagonist in the lung fluids of patients with the adult
respiratory distress syndrome. Ann Intern Med. 125:191–196. 1996.
View Article : Google Scholar
|
|
49
|
Lo CJ, Fu M and Cryer HG: Interleukin 10
inhibits alveolar macrophage production of inflammatory mediators
involved in adult respiratory distress syndrome. J Surg Res.
79:179–184. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Peng XD, Dai LL, Huang CQ, He CM, Yang B
and Chen LJ: Relationship between anti-fibrotic effect of Panax
notoginseng saponins and serum cytokines in rat hepatic
fibrosis. Biochem Biophys Res Commun. 388:31–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lee JS, Choi HS, Kang SW, et al:
Therapeutic effect of Korean red ginseng on inflammatory cytokines
in rats with focal cerebral ischemia/reperfusion injury. Am J Chin
Med. 39:83–94. 2011. View Article : Google Scholar : PubMed/NCBI
|
